These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 18991100

  • 1. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Habib HM, Mosaad YM, Youssef HM.
    Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
    [Abstract] [Full Text] [Related]

  • 2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [Abstract] [Full Text] [Related]

  • 3. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
    van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, Dijkmans B, van Venrooij WJ.
    J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Kasapçopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-Göksel A, Saribas S, Arisoy N, Kocazeybek B.
    Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
    [Abstract] [Full Text] [Related]

  • 5. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.
    Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM.
    Arthritis Rheum; 2005 Jan; 52(1):239-46. PubMed ID: 15641089
    [Abstract] [Full Text] [Related]

  • 6. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
    Dewint P, Hoffman IE, Rogge S, Joos R, Union A, Dehoorne J, Delanghe J, Veys EM, De Keyser F, Elewaut D.
    Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
    [Abstract] [Full Text] [Related]

  • 7. Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.
    Skare TS, Nisihara RM, Silva RM, Munhoz da Silva DJ, Gameiro Silva MB, Utiyama SR.
    J Clin Rheumatol; 2011 Dec; 17(8):421-3. PubMed ID: 22089992
    [Abstract] [Full Text] [Related]

  • 8. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF, Zhang QB, Zhou JG, Yuan GH, Wei J, Xing Y, Liu JP, Jiang L, Chen JP.
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [Abstract] [Full Text] [Related]

  • 9. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 10. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
    Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, Viola S, Martini A.
    Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H, Cambridge G, Bourke L, Sen D, Radziszewska A, Leandro M, Ioannou Y.
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [Abstract] [Full Text] [Related]

  • 12. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L, Marquez J, Gonzalez C, Santos AM, Londoño J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR.
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [Abstract] [Full Text] [Related]

  • 13. Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy children.
    Maeno N, Takei S, Fujikawa S, Yamada Y, Imanaka H, Hokonohara M, Kawano Y, Oda H.
    J Rheumatol; 2004 Jun; 31(6):1211-7. PubMed ID: 15170938
    [Abstract] [Full Text] [Related]

  • 14. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].
    Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM.
    Biomedica; 2004 Jun; 24(2):140-52. PubMed ID: 15495594
    [Abstract] [Full Text] [Related]

  • 18. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
    Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA.
    Arthritis Res Ther; 2005 Jun; 7(3):R592-603. PubMed ID: 15899046
    [Abstract] [Full Text] [Related]

  • 19. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C, Us T, Kaşifoğlu T, Akgün Y.
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M, Miu N, Bolba C, Iancu M, Spârchez Z, Rednic S.
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.